Status:
COMPLETED
Erythroferrone and Its Impact on Maternal and Neonatal Iron Homeostasis
Lead Sponsor:
Cornell University
Collaborating Sponsors:
University of California, Los Angeles
Conditions:
Pregnancy Anemia
Newborn; Anemia
Eligibility:
FEMALE
11-45 years
Brief Summary
Erythroferrone (ERFE) is a recently identified iron-regulatory hormone that couples iron homeostasis to erythropoiesis but at this time there are no human data on this hormone in pregnant women and th...
Eligibility Criteria
Inclusion
- Healthy pregnant volunteers
Exclusion
- Hemoglobinopathies
- Pre-existing diabetes
- Malabsorption diseases
- Pregnancy induced hypertension
- Elevated diastolic blood pressure (\>110)
- Previous treatment for lead exposure or elevated childhood lead concentrations.
- Preexisting medical conditions known to impact iron homeostasis
Key Trial Info
Start Date :
April 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
338 Patients enrolled
Trial Details
Trial ID
NCT04517734
Start Date
April 1 2006
End Date
December 1 2017
Last Update
March 22 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Rochester Adolescent Maternity Program
Rochester, New York, United States, 14609
2
Strong Memorial Hospital
Rochester, New York, United States, 14620